Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas Thornton

Showing results (61-70 of 81) with videos related to

Pageof 9
Sort By:
Journal of Racial and Ethnic Health Disparities|September 25, 2025
Racial and Ethnic Disparities in Cancer Mortality and Mediating Effects of Sociodemographic, Clinicopathologic, and Treatment FactorsOlajumoke A Olateju, Hassan E Arekemase, Hemalkumar B Mehta, et al.
Patient Preference and Adherence|November 12, 2020
Comparative Adherence Trajectories of Oral Fingolimod and Injectable Disease Modifying Agents in Multiple SclerosisJagadeswara R Earla, George J Hutton, J Douglas Thornton, et al.
Substance Use : Research and Treatment|March 4, 2024
Opioid Overdose Hospitalizations During COVID-19: The Experience of PennsylvaniaChan Shen, James Douglas Thornton, Ning Li, et al.
Journal of the American Pharmacists Association : Japha|November 14, 2022
Parents' intention to have their child vaccinated at a community pharmacy: A national cross-sectional surveyTyler J Varisco, Callie G Downs, Sujit S Sansgiry, et al.
The Oncologist|November 9, 2023
Opioid and Non-Opioid Pharmacotherapy Use for Pain Management Among Privately Insured Pediatric Patients With Cancer in the United StatesChan Shen, J Douglas Thornton, Ning Li, et al.
Exploratory Research in Clinical and Social Pharmacy|April 28, 2022
Factors associated with oral fingolimod use over injectable disease- modifying agent use in multiple sclerosisJagadeswara Rao Earla, George J Hutton, J Douglas Thornton, et al.
Journal of the American Pharmacists Association : Japha|May 21, 2021
Switching pharmacies leads to gaps in medication possession in individuals treated with buprenorphineTyler J Varisco, Susan Abughosh, Hua Chen, et al.
Frontiers in Reproductive Health|May 3, 2024
The role of economic evaluations in advancing HIV multipurpose prevention technologies in early-stage developmentKaterina Chapman, Sergio Torres-Rueda, Mutsumi Metzler, et al.
Scientific Reports|December 11, 2020
Trends and patterns in the use of opioids among metastatic breast cancer patientsChan Shen, J Douglas Thornton, Kristina Newport, et al.
The Oncologist|May 12, 2020
Prolonged Opioid Use After Surgery for Early-Stage Breast CancerChan Shen, J Douglas Thornton, Dian Gu, et al.
Pageof 9

Showing results (61-70 of 81) with videos related to

Sort By:
Pageof 9
Journal of Racial and Ethnic Health Disparities|September 25, 2025
Racial and Ethnic Disparities in Cancer Mortality and Mediating Effects of Sociodemographic, Clinicopathologic, and Treatment FactorsOlajumoke A Olateju, Hassan E Arekemase, Hemalkumar B Mehta, et al.
Patient Preference and Adherence|November 12, 2020
Comparative Adherence Trajectories of Oral Fingolimod and Injectable Disease Modifying Agents in Multiple SclerosisJagadeswara R Earla, George J Hutton, J Douglas Thornton, et al.
Substance Use : Research and Treatment|March 4, 2024
Opioid Overdose Hospitalizations During COVID-19: The Experience of PennsylvaniaChan Shen, James Douglas Thornton, Ning Li, et al.
Journal of the American Pharmacists Association : Japha|November 14, 2022
Parents' intention to have their child vaccinated at a community pharmacy: A national cross-sectional surveyTyler J Varisco, Callie G Downs, Sujit S Sansgiry, et al.
The Oncologist|November 9, 2023
Opioid and Non-Opioid Pharmacotherapy Use for Pain Management Among Privately Insured Pediatric Patients With Cancer in the United StatesChan Shen, J Douglas Thornton, Ning Li, et al.
Exploratory Research in Clinical and Social Pharmacy|April 28, 2022
Factors associated with oral fingolimod use over injectable disease- modifying agent use in multiple sclerosisJagadeswara Rao Earla, George J Hutton, J Douglas Thornton, et al.
Journal of the American Pharmacists Association : Japha|May 21, 2021
Switching pharmacies leads to gaps in medication possession in individuals treated with buprenorphineTyler J Varisco, Susan Abughosh, Hua Chen, et al.
Frontiers in Reproductive Health|May 3, 2024
The role of economic evaluations in advancing HIV multipurpose prevention technologies in early-stage developmentKaterina Chapman, Sergio Torres-Rueda, Mutsumi Metzler, et al.
Scientific Reports|December 11, 2020
Trends and patterns in the use of opioids among metastatic breast cancer patientsChan Shen, J Douglas Thornton, Kristina Newport, et al.
The Oncologist|May 12, 2020
Prolonged Opioid Use After Surgery for Early-Stage Breast CancerChan Shen, J Douglas Thornton, Dian Gu, et al.
Pageof 9